Generic medicine contains the same active ingredient in the same dose as the original brand.
Academic rigour, journalistic flair
Articles on Pharmaceuticals
Displaying 141 - 160 of 201 articles
Whether you cheered the election result or were cast into a depression, it doesn’t really matter. The real power lies outside of Westminster, and outside of our control.
Proposals for a new way to fund antibiotic research and development are just one piece of the puzzle in the fight against drug-resistance.
The cost of treatment is one of the biggest areas of the NHS budget and one of the most sensitive areas of discussion. We would all like to have an infinite amount of money to spend treating diseases and…
One of the much-heralded platforms of the Abbott government is its promise to business to reduce red tape and burdensome regulatory obligations. Pharmaceuticals are a multi-billion dollar global industry…
The rise of bacteria that are resistant to antibiotics is a growing worry and threatens to put healthcare back to the early 20th century. Such resistance to drugs was inevitable, because bacteria evolve…
Have you ever been advised to take a medicine with food? How about taking a medicine with cola or avoiding grapefruit? Hundreds of medicines have food-related dosing instructions. With four out of five…
A parliamentary bill proposing that the UK allocate 0.7% of its GDP for international aid has led to the usual criticism levelled against international aid: that in times of austerity, the country can’t…
In the last six months Colorado, Louisiana, Missouri, Michigan and, most recently, Arizona have passed “right to try” laws that allow terminally ill patients to access treatments that have only passed…
Imagine being pregnant while having a chronic health condition such as diabetes, hypertension, depression or asthma, or being diagnosed with an illness while pregnant. Amazingly, your doctor may not know…
On November 4, the state of Arizona will decide whether to join Colorado, Missouri, Louisiana and Michigan in passing so-called right to try laws. If passed, the “Arizona Terminal Patients’ Right To Try…
Ten years on from the Australia-US Free Trade Agreement, Australia is entering another round of negotiations towards the new and controversial Trans-Pacific Partnership. In this Free Trade Scorecard series…
Ten years on from the Australia-US Free Trade Agreement, Australia is entering another round of negotiations towards the new and controversial Trans-Pacific Partnership. In this Free Trade Scorecard series…
The Ebola crisis brings into sharp contrast the importance of appropriate regulation for trials of new drugs. The “gold standard” in clinical research is the randomised trial, but the reliance on one particular…
Ten years on from the Australia-US Free Trade Agreement, Australia is entering another round of negotiations towards the new and controversial Trans-Pacific Partnership. In this Free Trade Scorecard series…
Here’s what I remember. It was 14 years ago, and I was a junior doctor working in psychiatry. Some colleagues planned a dinner as an end-of-term celebration and, despite reasonable incomes, they decided…
The furore over US pharmaceuticals giant Pfizer’s attempted takeover of UK rival AstraZeneca continues. AstraZeneca has now rejected Pfizer’s “final” offer, as it says the proposed deal “undervalues the…
Pfizer is like Woody Allen’s famous shark. It has to keep moving or it will die. And the drug company seems unable to keep moving by any means other than acquisitions. Its all-time best-selling drug, Lipitor…
Congratulations are in order. The pair have known each other for some time. But the relationship has now been formalised. Living as we do in modern times, both may have other relationships, but it’s still…
Med City was launched to great fanfare last week by the Mayor of London, Boris Johnson. Bringing together the powerhouses of academic and clinical research at UCL, Imperial, Kings, Oxford and Cambridge…
Job Board
-
Project Offier - Diversity & Inclusion
-
Senior Lecturer - Earth System Science
-
Sydney Horizon Educators (Identified)
-
Deputy Social Media Producer
-
Associate Professor, Occupational Therapy
Top contributors
-
Associate Professor of the School of Pharmacy, University of Sydney
-
Joel Lexchin is a Friend of The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
-
Conjoint Clinical Associate Professor, Deakin University School of Medicine and Specialist Pain Medicine Physician, Deakin University
-
Lecturer Pharmacy Practice, University of Sydney
-
Pharmacist and PhD Candidate, University of Sydney
-
HERA Program Director - Health Workforce Optimisation Centre for the Business & Economics of Health, The University of Queensland
-
Assistant Professor, Bond University
-
PhD Candidate, Swinburne University of Technology
-
Research associate, University of Pretoria
-
Research Fellow, Stellenbosch University
-
Lecturer in Accounting & Management, Lancaster University
-
ARC Future Fellow, Australian National University
-
Purple House Medical Advisor. Honorary ANU., Australian National University
-
Associate Professor, School of Law, University of Canberra
-
Professor of Bioethics, Macquarie University
